Barclays lowered the firm’s price target on UnitedHealth (UNH) to $513 from $560 and keeps an Overweight rating on the shares following the Q1 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target lowered to $525 from $655 at RBC Capital
- Optimistic Long-Term Outlook for UnitedHealth Despite Near-Term Challenges
- CoreWeave initiated, eBay downgraded: Wall Street’s top analyst calls
- UnitedHealth price target lowered to $563 from $664 at Morgan Stanley
- UnitedHealth downgraded to Hold from Buy at HSBC